Syamantak Majumder1,2, Mitchell J Hadden1, Karina Thieme1,3, Sri N Batchu1, Divya Niveditha2, Shibasish Chowdhury2, Veera Ganesh Yerra1, Suzanne L Advani1, Bridgit B Bowskill1, Youan Liu1, Hana Vakili1,4, Tamadher A Alghamdi1, Kathryn E White5, Laurette Geldenhuys6, Ferhan S Siddiqi7, Andrew Advani8. 1. Keenan Research Centre for Biomedical Science and Li Ka Shing Knowledge Institute, St Michael's Hospital, 209 Victoria Street, Toronto, ON, M5C 1T8, Canada. 2. Department of Biological Sciences, Birla Institute of Technology and Science (BITS), Pilani, Rajasthan, India. 3. Department of Physiology and Biophysics, Institute of Biomedical Sciences, University of São Paulo, São Paulo, Brazil. 4. Department of Pathology, University of Texas Southwestern Medical Center, Dallas, TX, USA. 5. Electron Microscopy Research Services, Newcastle University, Newcastle upon Tyne, UK. 6. Department of Pathology, Dalhousie University, Halifax, NS, Canada. 7. Department of Medicine, Dalhousie University, Halifax, NS, Canada. 8. Keenan Research Centre for Biomedical Science and Li Ka Shing Knowledge Institute, St Michael's Hospital, 209 Victoria Street, Toronto, ON, M5C 1T8, Canada. advania@smh.ca.
Abstract
AIMS/HYPOTHESIS: Long non-coding RNAs (lncRNAs) are garnering increasing attention for their putative roles in the pathogenesis of chronic diseases, including diabetic kidney disease (DKD). However, much about in vivo lncRNA functionality in the adult organism remains unclear. To better understand lncRNA regulation and function in DKD, we explored the effects of the modular scaffold lncRNA HOTAIR (HOX antisense intergenic RNA), which approximates chromatin modifying complexes to their target sites on the genome. METHODS: Experiments were performed in human kidney tissue, in mice with streptozotocin-induced diabetes, the db/db mouse model of type 2 diabetes, podocyte-specific Hotair knockout mice and conditionally immortalised mouse podocytes. RESULTS: HOTAIR was observed to be expressed by several kidney cell-types, including glomerular podocytes, in both human and mouse kidneys. However, knockout of Hotair from podocytes had almost no effect on kidney structure, function or ultrastructure. Glomerular HOTAIR expression was found to be increased in human DKD, in the kidneys of mice with streptozotocin-induced diabetes and in the kidneys of db/db mice. Likewise, exposure of cultured mouse podocytes to high glucose caused upregulation of Hotair expression, which occurred in a p65-dependent manner. Although HOTAIR expression was upregulated in DKD and in high glucose-exposed podocytes, its knockout did not alter the development of kidney damage in diabetic mice. Rather, in a bioinformatic analysis of human kidney tissue, HOTAIR expression closely paralleled the expression of its genic neighbour, HOXC11, which is important to developmental patterning but which has an uncertain role in the adult kidney. CONCLUSIONS/ INTERPRETATION: Many lncRNAs have been found to bind to the same chromatin modifying complexes. Thus, there is likely to exist sufficient redundancy in the system that the biological effects of dysregulated lncRNAs in kidney disease may often be inconsequential. The example of the archetypal scaffold lncRNA, HOTAIR, illustrates how lncRNA dysregulation may be a bystander in DKD without necessarily contributing to the pathogenesis of the condition. In the absence of in vivo validation, caution should be taken before ascribing major functional roles to single lncRNAs in the pathogenesis of chronic diseases.
AIMS/HYPOTHESIS: Long non-coding RNAs (lncRNAs) are garnering increasing attention for their putative roles in the pathogenesis of chronic diseases, including diabetic kidney disease (DKD). However, much about in vivo lncRNA functionality in the adult organism remains unclear. To better understand lncRNA regulation and function in DKD, we explored the effects of the modular scaffold lncRNA HOTAIR (HOX antisense intergenic RNA), which approximates chromatin modifying complexes to their target sites on the genome. METHODS: Experiments were performed in human kidney tissue, in mice with streptozotocin-induced diabetes, the db/db mouse model of type 2 diabetes, podocyte-specific Hotair knockout mice and conditionally immortalised mouse podocytes. RESULTS:HOTAIR was observed to be expressed by several kidney cell-types, including glomerular podocytes, in both human and mouse kidneys. However, knockout of Hotair from podocytes had almost no effect on kidney structure, function or ultrastructure. Glomerular HOTAIR expression was found to be increased in human DKD, in the kidneys of mice with streptozotocin-induced diabetes and in the kidneys of db/db mice. Likewise, exposure of cultured mouse podocytes to high glucose caused upregulation of Hotair expression, which occurred in a p65-dependent manner. Although HOTAIR expression was upregulated in DKD and in high glucose-exposed podocytes, its knockout did not alter the development of kidney damage in diabeticmice. Rather, in a bioinformatic analysis of human kidney tissue, HOTAIR expression closely paralleled the expression of its genic neighbour, HOXC11, which is important to developmental patterning but which has an uncertain role in the adult kidney. CONCLUSIONS/ INTERPRETATION: Many lncRNAs have been found to bind to the same chromatin modifying complexes. Thus, there is likely to exist sufficient redundancy in the system that the biological effects of dysregulated lncRNAs in kidney disease may often be inconsequential. The example of the archetypal scaffold lncRNA, HOTAIR, illustrates how lncRNA dysregulation may be a bystander in DKD without necessarily contributing to the pathogenesis of the condition. In the absence of in vivo validation, caution should be taken before ascribing major functional roles to single lncRNAs in the pathogenesis of chronic diseases.
Authors: Jing Zhao; Toshiro K Ohsumi; Johnny T Kung; Yuya Ogawa; Daniel J Grau; Kavitha Sarma; Ji Joon Song; Robert E Kingston; Mark Borowsky; Jeannie T Lee Journal: Mol Cell Date: 2010-12-22 Impact factor: 17.970
Authors: Lingjie Li; Bo Liu; Orly L Wapinski; Miao-Chih Tsai; Kun Qu; Jiajing Zhang; Jeff C Carlson; Meihong Lin; Fengqin Fang; Rajnish A Gupta; Jill A Helms; Howard Y Chang Journal: Cell Rep Date: 2013-09-26 Impact factor: 9.423
Authors: Juan F Navarro-González; Carmen Mora-Fernández; Mercedes Muros de Fuentes; Javier García-Pérez Journal: Nat Rev Nephrol Date: 2011-05-03 Impact factor: 28.314
Authors: Ahmad M Khalil; Mitchell Guttman; Maite Huarte; Manuel Garber; Arjun Raj; Dianali Rivea Morales; Kelly Thomas; Aviva Presser; Bradley E Bernstein; Alexander van Oudenaarden; Aviv Regev; Eric S Lander; John L Rinn Journal: Proc Natl Acad Sci U S A Date: 2009-07-01 Impact factor: 11.205
Authors: Ferhan S Siddiqi; Syamantak Majumder; Kerri Thai; Moustafa Abdalla; Pingzhao Hu; Suzanne L Advani; Kathryn E White; Bridgit B Bowskill; Giuliana Guarna; Claudia C Dos Santos; Kim A Connelly; Andrew Advani Journal: J Am Soc Nephrol Date: 2015-11-03 Impact factor: 10.121
Authors: Quan Hong; Ou Li; Wei Zheng; Wen-Zhen Xiao; Lu Zhang; Di Wu; Guang-Yan Cai; John Cijiang He; Xiang-Mei Chen Journal: Cell Death Dis Date: 2017-05-11 Impact factor: 8.469
Authors: B Alipoor; S Nikouei; F Rezaeinejad; S-N Malakooti-Dehkordi; Z Sabati; H Ghasemi Journal: J Endocrinol Invest Date: 2021-04-01 Impact factor: 4.256
Authors: Vianet Argelia Tello-Flores; Fredy Omar Beltrán-Anaya; Marco Antonio Ramírez-Vargas; Brenda Ely Esteban-Casales; Napoleón Navarro-Tito; Luz Del Carmen Alarcón-Romero; Carlos Aldair Luciano-Villa; Mónica Ramírez; Óscar Del Moral-Hernández; Eugenia Flores-Alfaro Journal: Int J Mol Sci Date: 2021-07-06 Impact factor: 5.923
Authors: Kun Chi; Xiaodong Geng; Chao Liu; Yang Zhang; Jie Cui; GuangYan Cai; Xiangmei Chen; Fangfang Wang; Quan Hong Journal: J Cell Mol Med Date: 2021-07-22 Impact factor: 5.310